Since PD‐L1 expression is considered to mediate stem cell resistance, knowledge about strategies to block PD‐L1 expression in MPN NSC may provide a suitable basis for the design of improved NSC‐targeting treatment strategies. This evidence concerns the gene CD274 and myeloproliferative disorder.